| | | |   | | | | By Ed Silverman Milken Institute "I’m sorry, but think about how ludicrous your point is," Regeneron president George Yancopoulos said to the panel moderator. Read More | | By Ed Silverman Alex Hogan/STAT From new hires to departures, promotions, and transfers, here are the latest comings and goings in the pharmaceutical industry. Read More | | By Mohana Ravindranath Milken Institute Technology can exacerbate health care disparities, or it can start to close gaps in access. Here's what can make the difference. Read More | | Sponsored Insight by Genentech Leading biotech company outlines its approach for achieving economic sustainability in cancer care The ultimate goal? A future with better outcomes for cancer patients at a lower cost to society. Hear how Genentech is working on multiple fronts — from developing and delivering treatments in ways that account for patient preference to pricing medicines responsibly — to define and improve the value of cancer care for patients, providers, and our healthcare system. Read more from Elaine Yu, head of evidence for access oncology at Genentech. | | By Michael Elashoff Adobe Health AI sits between health care and tech. Like the border between two nations, there are significant differences on either side. Read More | |
No comments